Management of advanced parotid cancer. A systematic review

European Journal of Surgical Oncology

Volumn 35, Issue 9, 2009, Pages 908-915

  Jeannon, J P ^a   Calman, F ^a   Gleeson, M ^a   McGurk, M ^a   Morgan, P ^a   O'Connell, M ^a   Odell, E ^a   Simo, R ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Advanced stage; High grade; Parotid carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; ADVANCED CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; DISTANT METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PAROTID GLAND CANCER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR GROWTH;

ADENOCARCINOMA; HUMANS; NEOPLASM STAGING; PAROTID NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 68249090093     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.10.009     Document Type: Review

References (34)

1. AJCC. Major salivary glands (parotid, submandibular, and sublingual). American Joint Committee on Cancer: AJCC cancer staging manual. 5th ed. (1997), Lippincott-Raven, Philadelphia, PA p. 53-58
2. Armstrong J.G., Harrison L.B., Thaler H.T., et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69 3 (1992) 615-619
3. Bhattacharyya N., and Fried M.P. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol 26 1 (2005) 39-44
4. Mendenhall W.M., Morris C.G., Amdur R.J., Werning J.W., and Villaret D.B. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 103 12 (2005) 2544-2550
5. Luukkaa H., Klemi P., Leivo I., Koivunen P., Laranne J., Makitie A., et al. Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases. Acta Otolaryngol 125 2 (2005) 207-214
6. Terhaard C.H., Lubsen H., Rasch C.R., et al. Dutch Head and Neck Oncology Cooperative Group. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61 1 (2005) 103-111
7. Spiro R.H., Armstrong J., Harrison L., Geller N.L., Lin S.Y., and Strong E.W. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg 115 3 (1989) 316-321
8. Renehen A.G., Gleave E.N., Slevin N., and McGurk M. Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer 80 8 (1999) 1296-1300
9. Lima R.A., Tavares M.R., Dias F.L., et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 133 5 (2005) 702-708
10. Goode R.K., Auclair P.L., and Ellis G.L. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 82 7 (1998) 1217-1224
11. Pedersen D., Overgaard J., Sogaard H., Elbrond O., and Overgaard M. Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 102 9 (1992) 1064-1069
12. Boahene D.K., Olsen K.D., Lewis J.E., Pinheiro A.D., Pankratz V.S., and Bagniewski S.M. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. Arch Otolaryngol Head Neck Surg 130 7 (2004) 849-856
13. Magnano M., Gervasio C.F., Cravero L., Lerda W., Orecchia R., and Ragona R. Therapeutic strategies for the treatment of parotid gland malignancies. Acta Otorhinolaryngol 18 3 (1998) 164-171
14. Charabi S., Balle V., Charabi B., Nielsen P., and Thomsen J. Surgical outcome in malignant parotid tumours. Acta Otolaryngol 543 Suppl (2000) 251-253
15. Kirkbride P., Liu F.F., O'Sullivan B., et al. Outcome of curative management of malignant tumours of the parotid gland. J Otolaryngol 30 5 (2001) 271-279
16. Harbo G., Bundgaard T., Pedersen D., Sogaard H., and Overgaard J. Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol Allied Sci 27 6 (2002) 512-516
17. Pohar S., Gay H., Rosenbaum P., et al. Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys 61 1 (2005) 112-118
18. Carinci F., Farina A., Pelucchi S., Calearo C., and Pastore A. Parotid gland carcinoma: surgical strategy based on local risk factors. J Craniofac Surg 12 5 (2001) 434-437
19. Ball A.B., Fish S., and Thomas J.M. Malignant epithelial parotid tumours: a rational treatment policy. Br J Surg 82 5 (1995) 621-623
20. Frankenthaler R.A., Luna M.A., Lee S.S., et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 117 11 (1991) 1251-1256
21. van der Wal J.E., Snow G.B., and van der Waal I. Histological reclassification of 101 intraoral salivary gland tumours (new WHO classification). J Clin Pathol 45 9 (1992) 834-835
22. Tischendorf L., Herrmann P.K., and Luttermann T. Implications of the reclassification study of tumors of the salivary glands of the head. Deutsche Zeitschr Mund Kiefer Gesichts Chir 15 1 (1991) 35-37
23. Chen A.M., Garcia J., Lee N.Y., Bucci M.K., and Eisele D.W. Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation?. Int J Radiat Oncol Biol Phys 67 (2007) 988-994
24. Dorairajan N., Periyasamy S., Muthayya P., Manikandan R., Srinivasan T., and Siddharth D. Salivary gland tumors: a 10-year retrospective study of survival in relation to size, histopathological examination of the tumor, and nodal status. Int Surg 89 3 (2004) 140-149
25. Zbaren P., Schupbach J., and Nuyens M. Stauffer E Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg 132 3 (2005) 387-391
26. Chen A.M., Granchi P.J., Garcia J., Bucci M.K., Fu K.K., and Eisele D.W. Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 67 (2007) 982-987
27. Olsen K.D., and Lewis J.E. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 23 (2001) 705-712
28. Garden A.S., Weber R.S., Morrison W.H., Ang K.K., and Peters L.J. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 32 3 (1995) 619-626 15
29. Huber P.E., Debus J., Latz D., et al. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?. Radiother Oncol 59 (2001) 161-167
30. Laramore G.E., Krall J.M., Griffin T.W., et al. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 27 (1993) 235-240
31. Airoldi M., Cortesina G., Giordano C., et al. Update and perspectives on non-surgical treatment of salivary gland malignancies. Acta Otorhinolaryngol Ital 23 (2003) 368-376
32. Airoldi M., Fornari G., Pedani F., et al. Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 20 (2000) 3781-3783
33. Gilbert J., Li Y., Pinto H.A., et al. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group. Head Neck 28 (2006) 197-204
34. Sorensen K.B., Godballe C., de Stricker K., and Krogdahl A. Parotid carcinoma: expression of kit protein and epidermal growth factor receptor. J Oral Pathol Med 35 5 (2006) 286-291